About
About Mustang Bio
Leadership
Board of Directors
In the News
Contact
Our Approach
Our Approach
About CAR T Cell Therapy
Publications
Manufacturing
Pipeline
Pipeline
Clinical Trials
Partnering
Partnering
Active Collaborations
Careers
Investor Relations
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-12G
10-12G/A
10-K
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
EFFECT
PRE 14A
PRE 14C
PRER14C
PX14A6G
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
Date
Form
Description
PDF
XBRL
Pages
04/28/21
UPLOAD
SEC-generated letter
Documents
expand_more
TEXT-EXTRACT
1
04/23/21
S-3
Registration statement for specified transactions by certain issuers
Documents
expand_more
EX-5.1
EX-23.1
16
04/20/21
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
50
04/16/21
4
Statement of changes in beneficial ownership of securities
2
04/12/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
04/02/21
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
expand_more
EX-5.1
EX-23.2
6
03/24/21
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
expand_more
EX-4.3
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
116
03/24/21
8-K
Current report filing
Documents
expand_more
EX-99.1
6
03/15/21
4
Statement of changes in beneficial ownership of securities
2
03/15/21
4
Statement of changes in beneficial ownership of securities
2
rss_feed
Filing RSS
arrow_back
1
…
13
14
15
16
17
18
19
20
21
22
…
35
arrow_forward
Email Alerts
Contacts
RSS News Feed